Sage Therapeutics, Inc. Deferred Offering Costs
Sage Therapeutics, Inc. had Deferred Offering Costs of $200.00 thousand as of 2015-12-31, per its 10-K filed 2017-02-24.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2017-02-24
- 2015-12-31: Deferred Offering Costs $200.00K.
- 2015-06-30: Deferred Offering Costs $0.00.
- 2015-03-31: Deferred Offering Costs $186.00K.
- 2014-12-31: Deferred Offering Costs $10.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2015-12-31 | $200.00K 10-K · filed 2017-02-24 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 |
| 2015-03-31 | $186.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $10.00K 10-Q · filed 2015-08-12 |
| 2014-09-30 | $2.28M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.64M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $0.00 10-Q · filed 2014-08-14 |